Africa is counted amongst the cosmetic market contributors; however, South Africa’s remarkable plant diversity is still largely untapped in terms of its potential for medicinal and cosmetic purposes. Thus, we aim to provide a critical assessment of the advancements made in South African cosmeceuticals with emphasis towards online local companies/brands that are manufactured by small, medium and micro enterprises (SMMEs). For the current study, we limited our search of herbal cosmeceutical products to SMMEs with online websites, or products traded in other online cosmetic directories such as ‘Faithful to Nature’ and ‘African Botanicals’ using a simple Google search. We recorded more than 50 South African SMME companies/brands involved in the trade of cosmeceuticals. Skin and hair care were the major product categories widely traded in these online platforms. Furthermore, few patents were recorded from South African researchers and institutions thereof, which is quite alarming considering the extensive research that has been undertaken to study these commercially valuable plants. Based on the increasing number of new products and the wide pool of economically important plants coupled to their associated rich indigenous knowledge systems, the cosmeceutical sector can contribute to the economy, job creation, entrepreneurship skills, socio-economic development and intellectual property generation.
Cannabis sativa L. is a monotypic genus belonging to the family Cannabaceae. It is one of the oldest species cultivated by humans, believed to have originated in Central Asia. In pivotal judgements in 2016 and 2018, the South African Constitutional Court legalised the use of Cannabis within the country for medicinal and recreational purposes, respectively. These decrees opened opportunities for in-depth research where previously there had been varying sentiments for research to be conducted on the plant. This review seeks to examine the history, genetic diversity, and chemical profile of Cannabis. The cultivation of Cannabis by indigenous people of southern Africa dates back to the eighteenth century. Indigenous rural communities have been supporting their livelihoods through Cannabis farming even before its legalisation. However, there are limited studies on the plant’s diversity, both morphologically and genetically, and its chemical composition. Also, there is a lack of proper documentation of Cannabis varieties in southern Africa. Currently, the National Centre for Biotechnology Information (NCBI) has 15 genome assemblies of Cannabis obtained from hemp and drug cultivars; however, none of these are representatives of African samples. More studies are needed to explore the species’ knowledge gaps on genetic diversity and chemical profiles to develop the Cannabis sector in southern Africa.
The rich biodiversity heritage in Africa positions it as a pivotal hub for phytochemical-based metabolomics research. This study maps the trajectory of this field through a systematic bibliometric analysis, triangulating datasets from Scopus, Web of Science, and Dimensions® (1970–2025) databases to ensure comprehensive coverage. By utilising machine-learning-aided curation, we refined the final dataset (n = 8,244) via Biblioshiny (R software) and Python-based metrics to identify the contributions aligned to eligible criteria. Using the corresponding-author country (leadership) attribution, the findings revealed a landscape of sustained scholarly growth, heavily concentrated within South Africa, Nigeria, and Cameroon. Collaboration dynamics remain uneven; while intercontinental partnerships drive significant output (43.67%), intra-African research networks are comparatively sparse, highlighting a fragmentation of regional expertise. Thematic evolution analysis uncovered a dichotomy in research focus. The field demonstrates increasing maturity in in vitro antioxidant and antimicrobial models, yet critical niches such as alkaloid characterisation and clinical translation remain underdeveloped. Furthermore, foundational methodological works continue to dominate citation patterns, suggesting a reliance on established protocols over novel experimental designs. Although there is a discernible shift toward molecular docking and computational metabolomics, persistent infrastructural gaps, ranging from database limitations to instrumentation deficits, have delayed the full integration of artificial intelligence into African research workflows. The field thrives as a biodiverse innovation frontier, yet translational inequities persist. Bridging these gaps requires a strategic pivot toward robust pan-African collaboration, the integration of advanced digital tools, and policies that centre Indigenous knowledge, thereby positioning Africa as a leader in equitable global drug discovery.